PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules

Published:2018-02-12 Issue:39 Volume:23 Page:6033-6041
ISSN:1381-6128
Container-title:Current Pharmaceutical Design
language:en
Short-container-title:CPD

Author:

Geng Qiaohong¹,Jiao Peifu¹,Jin Peng¹,Su Gaoxing²,Dong Jinlong³,Yan Bing⁴

Affiliation:

1. Department of Chemistry, Qilu Normal University, Jinan, Shandong 250013, China

2. School of Pharmacy, Nantong University, Nantong, Jiangsu 226001, China

3. Jinan Taorui Pharma & Tech Co., Ltd., Jinan, Shandong 250101, China

4. School of Environmental Science and Engineering, Shandong University, Jinan, Shandong 250100, China

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse effects of anti-cancer biologics on the ocular surface;Current Opinion in Allergy & Clinical Immunology;2024-07-04

2. Shedding Light on the Role of Exosomal PD-L1 (ExoPD-L1) in Cancer Progression: an Update;Cell Biochemistry and Biophysics;2024-06-22

3. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

4. Anterior Uveitis Secondary to Avelumab and Pembrolizumab in a Patient with Metastatic Renal Cell Carcinoma—A Case Report;Reports;2024-03-06

5. Uncovering the colorectal cancer immunotherapeutic potential: Evening primrose (Oenothera biennis) root extract and its active compound oenothein B targeting the PD-1/PD-L1 blockade;Phytomedicine;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP